| Market Cap | ₹44Cr |
| ROE | 0.87% |
| P/E Ratio(TTM) | -1.21 |
| EPS(TTM) | -7.22 |
| P/B Ratio | 0.78 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.30 |
| Book Value | 11.25 |
| Debt to Equity | 0.13 |
| Face Value | 10 |
| Managing Director | Dr. Omkar Pravin Herlekar |
| Founded | 2016 |
| NSE Symbol | LASA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.56 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 30.92 | ||
| Wockhardt | NA (0.00%) | -2228.87 | ||
| Natco Pharma | NA (0.00%) | 9.67 |